Screening for Depression and Anxiety in Patients With Heart Disease

Depression is a risk factor for morbidity and mortality in patients with heart disease, and has a negative impact on quality of life, work capacity and treatment adherence. Screening for depression among heart patients are therefore recommended by the Norwegian Health Authorities. Also, symptoms of anxiety may negatively affect rehabilitation due to e.g. fear of physical activity and excessive worry. Patients currently receiving treatment for heart disease at Diakonhjemmet Hospital will be screened for symptoms of depression and anxiety. If such symptoms are detected, patients will be offered a counselling session with a clinical psychologist. Further, routines for collaborative communication between clinical psychologist, cardiologist and the patient's general physician will be emphasized.

Study Overview

• Status: Completed
• Conditions: Depressive Disorder; Depression; Heart Diseases; Anxiety Disorders; Anxiety; Depressive Symptoms; Collaboration; Panic Attacks
• Intervention / Treatment: Behavioral: Screening and counselling

• Study Type: Interventional
• Enrollment (Actual): 232
• Phase: Not Applicable

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

Description

Inclusion Criteria:

• Men and women over 18 years under treatment for myocardial infarction, heart failure, tachyarrhythmia and/or valvular heart disease at the Department of Internal Medicine, Diakonhjemmet Hospital.

Exclusion Criteria:

• Unable to provide informed consent.
• Unable to read and/or understand Norwegian.
• Unable to complete a survey.

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Screening
• Allocation: N/A
• Interventional Model: Single Group Assignment
• Masking: None (Open Label)

Number of Arms

1

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: Heart patients; Screening and counselling	Behavioral: Screening and counselling; Screening for symptoms of depression and anxiety in heart patients, giving advice for prevention and managing of such symptoms and stimulating collaborative care between the hospital and the general practitioner.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Detection of symptoms of depression, anxiety and/or recent panic attack in heart patients.	All patients included in the study will be screened for symptoms of depression, anxiety and recent panic attack by filling out a survey consisting of questions from the Patient Health Questionnaire-2 (PHQ-2), the Generalized Anxiety Disorder Scale-2 (GAD-2) and a question about whether they experienced a panic attack in the last four weeks. Cut-off is set to a score of ≥ 2 on PHQ-2 and/or GAD-2 and/or a positive answer on the question about panic attack.	15 minutes
Detection of patients with or at risk for depression and/or anxiety disorders.	Patients who screened positive for symptoms of depression, anxiety and/or panic attack will be asked to complete the Hospital Anxiety and Depression Scale (HADS). Patients with a HADS score of ≥ 4 will be offered a counselling session with a clinical psychologist.	1 hour
Implementation of counselling for treatment and prevention of depression and anxiety disorders in heart patients.	Patients with a HADS score of ≥ 4 will be offered a counselling session with a clinical psychologist aimed to treat and prevent depression and anxiety disorders in heart patients.	1-2 hours

Collaborators and Investigators

• Sponsor: Diakonhjemmet Hospital
• Collaborators: Extrastiftelsen; LHL - The Norwegian Heart and Lung Patient Organization
• Investigators: Principal Investigator: Torkil Berge, Psychologist, Department of Psychiatry, Diakonhjemmet Hospital, Oslo, Norway

Study record dates

Study Major Dates

• Study Start (Actual): January 1, 2017
• Primary Completion (Actual): October 1, 2017
• Study Completion (Actual): October 1, 2017

Study Registration Dates

• First Submitted: June 23, 2017
• First Submitted That Met QC Criteria: June 27, 2017
• First Posted (Actual): June 29, 2017

Study Record Updates

• Last Update Posted (Actual): December 4, 2019
• Last Update Submitted That Met QC Criteria: December 3, 2019
• Last Verified: December 1, 2019

More Information

Terms related to this study

• Keywords: Depression; Anxiety; Collaborative Care; Panic Attacks; Heart disease and depression; Heart disease and anxiety; Heart disease and panic attacks
• Additional Relevant MeSH Terms: Behavioral Symptoms; Mental Disorders; Pathologic Processes; Cardiovascular Diseases; Mood Disorders; Heart Diseases; Depression; Depressive Disorder; Disease; Anxiety Disorders; Panic Disorder
• Other Study ID Numbers: 2016/16558 (PVO); 2016/16558 (Other Identifier: The Data Protection Officer (Personvernombudet))

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No